Dr. Mohamad Rasm R. Alsibae, MD

Dr. Alsibae practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Alsibae's NPI, 1326230038, was assigned on August 16, 2007. Dr. Alsibae holds Michigan license 4301082634.

Dr. Alsibae's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Alsibae's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Alsibae is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Alsibae to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsibae practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Alsibae's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Alsibae is licensed in Michigan.

CMS data shows 1,008 Medicare services from Dr. Alsibae across 6 procedure codes in 2024, for 445 Medicare patients. Medicare paid $79,977 for them.

CMS counts 445 Medicare patients who saw Dr. Alsibae in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alsibae's median patient age at 60, with 48% women.

In 2024, Dr. Alsibae wrote 3,687 Medicare Part D claims for 401 patients. 85% of them were for generic drugs. CMS names the drug for 3,424 of them, across 46 drugs with 11 or more claims each, at $1,303,058 in total drug cost. In 2023, CMS named 2,924 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Alsibae for performance year 2024, reported as part of a group. Dr. Alsibae accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alsibae as offering telehealth. CMS counts 46 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Alsibae, more than 62% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 146 general payments to Dr. Alsibae from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Madrigal Pharmaceuticals paid the most, $60,223.